Machine learning-guided discovery and molecular dynamics simulation of VISTA-targeted immunotherapeutics for cancer immunotherapy.

VISTA (V-domain Ig suppressor of T cell activation) is an emerging immunological checkpoint receptor that inhibits T cell activation, which is crucial for tumor immune evasion. Blocking the VISTA signaling pathway has emerged as a viable cancer immun…

Preview only. Read the full abstract at the source